Protagonist Therapeutics
PTGX
#2263
Rank
HK$63.86 B
Marketcap
HK$978.40
Share price
-1.93%
Change (1 day)
48.94%
Change (1 year)

P/S ratio for Protagonist Therapeutics (PTGX)

P/S ratio as of November 2026 (TTM): 29.4

According to Protagonist Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.86. At the end of 2026 the company had a P/S ratio of 27.8.

P/S ratio history for Protagonist Therapeutics from 2016 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202627.8-76.53%
20251182116%
20245.34-75.75%
202322.09.16%
202220.2-66.16%
202159.796.96%
202030.3-96.35%
201983116361.66%
20185.05-76.83%
201721.8
2016N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA